MDN Related News
Why MDMA must be reclassified as a Schedule 2 drug
Amanda Feilding of the Beckley Foundation discusses the organisations new report ‘Roadmaps to Regulation: MDMA’ which recommends rescheduling MDMA to a Schedule 2 drug.
MDMA...